Could Viking Therapeutics Next: Will It Challenge Lilly?
The race to own the GLP-1 weight loss market has a new challenger in Viking Therapeutics. This article breaks down wh...
Determining the right percentage of income to save for retirement is crucial for millennials. Find out the ideal savings rate for a secure future.
24,766 articlesThe race to own the GLP-1 weight loss market has a new challenger in Viking Therapeutics. This article breaks down wh...
A near-$150 million Polymarket contract is roiled as traders question payouts after Strategy disclosed BTC sales. The...
Cerebras has burst onto the Nasdaq scene, and Wall Street quickly weighed in with buys and cautious optimism. This ar...
Artificial intelligence is reshaping finance, but the question isn’t simply disruption or protection. This article di...
Biogen’s $1 billion move on a mystery company has investors buzzing. This article breaks down why the deal could be a...
Is a $5 trillion Apple valuation possible by the end of 2026? This guide weighs the growth engines, risks, and action...
Four buyers claim they paid an ex-NBA player for paintings, commissions, and jerseys that never arrived. This caution...
Chemed has faced a challenging year, even as its business lines stay essential. This article breaks down the drivers ...
Institutional activity in Bitcoin ETFs is more nuanced than daily inflows suggest. This piece examines how market mak...
NCS Multistage's Q4 2025 earnings call offers insight into margins, backlog, and growth drivers. This guide translate...
Lumentum Holdings stock zoomed after a positive investor briefing at a major industry conference and a rising price t...
Berkshire Hathaway just resumed stock buybacks after a long pause, signaling a shift in capital allocation. This arti...